1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Natasha Appelman-Dijkstra: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) Denosumab 120 Mg/1.7 Ml Inj, Placebo - Fibrous Dysplasia, McCune Albright Syndrome | Phase 4 | Recruiting | Natasha Appelman-Dijkstra | 82 | 2023-06-13 | 2025-01-29 |
Fibrous Dysplasia of Bone (1) · Fibrous Dysplasia, Polyostotic (1)
Denosumab (1)
Netherlands (1)